FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to an antiproliferative agent for treating benign hyperplasia of prostate (BHP). The antiproliferative agent for treating benign hyperplasia of prostate based on herbal raw materials represents terrestrial peat lipids prepared by grinding terrestrial peat in a planetary ball mill or a ball mill, extracting ground peat in mixed ethanol and chloroform, filtering, evaporating and drying in the specific environment.
EFFECT: agent enables extending the range of herbal products on the basis of domestic herbal raw materials effective in treating BHP.
3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIPROLIFERATIVE AGENT | 2011 |
|
RU2519727C2 |
| METHOD FOR PREVENTING AND TREATING BENIGN PROSTATIC HYPERPLASIA | 2014 |
|
RU2574014C2 |
| METHOD AND REMEDY FOR TREATMENT AND PREVENTION OF BENIGN PROSTATIC HYPERPLASIA | 2019 |
|
RU2764850C1 |
| PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF PROSTATE PATHOLOGIES | 2017 |
|
RU2750992C2 |
| LOW-TOXIC 1,3,4-OXADIAZOLE DERIVATIVES OF DEOXYCHOLIC ACID WITH PROSTATE-PROTECTIVE AND ANTI-INFLAMMATORY ACTION | 2023 |
|
RU2819604C1 |
| MEDICATION (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF CHEMOPROPHYLAXIS OF PROSTATE PRE-CANCER AND CANCER | 2012 |
|
RU2571818C2 |
| 1,2,4-OXADIAZOLE DERIVATIVES OF DESOXYCHOLIC ACID, EXHIBITING PROSTATE-PROTECTIVE EFFECT, HYPOCHOLESTEROLEMIC AND ANTI-INFLAMMATORY ACTIVITY | 2020 |
|
RU2750488C1 |
| MEANS AND METHOD OF CONDITIONS TREATMENT IMPLYING ANDROGEN ACTION DECREASE IS CONSIDERED TO BE FAVOURABLE, AND METHOD OF ANDROGEN-DEPENDENT TISSUE SENSITIVITY ITENSIFYING USING 9-OXOACRIDINE-10-ACETIC ACID | 2006 |
|
RU2328285C2 |
| METHOD TO DECREASE DEVELOPMENT OF 5-ALPHA-DIHYDROTESTOSTERONE IN MEN AT AGE ANDROGENIC DEFICIENCY | 1999 |
|
RU2179852C2 |
| AGENT FOR REDUCING PATHOLOGICAL CHANGES IN PROSTATIC HYPERPLASIA | 2020 |
|
RU2740946C1 |
